Blog - Page 3544 of 5743

WednesdayMay 04, 2011 9:31 am

Akorn Inc. (AKRX) to Acquire Advanced Vision Research, Inc.

Yesterday, generic pharmaceutical company Akorn, Inc. announced that it has entered into an agreement to acquire Advanced Vision Research, Inc. Based in Woburn, MA AVR is a premier over-the-counter ophthalmic company that develops and markets eye care products under the TheraTears® and MacuTrition® brand names. In 2010, AVR generated sales of $20 million, which consisted of domestic sales through major retail chains and sales in 20 countries across 5 continents. Akorn also announced plans to launch a new Consumer Health Division to enter the $1.2 billion over the counter eye care market, pending the acquisition of AVR. Akorn will license…

WednesdayMay 04, 2011 9:28 am

True 2 Beauty, Inc. (TRTB) Charges Forward with a Superior Product Line and History of Success

A leading manufacturer and distributor of sexual potency pills and liquid products in the United States, True 2 Beauty, Inc. offers a line of products that currently includes Libigrow, Libigirl, Libiliquid Shots, XXXTREME and T.N.T. The company's products are regarded as the most powerful over the counter herbal sexual and performance supplements available on the market. Containing only natural ingredients, the Libigrow product line is formulated to increase sexual desire and confidence, increase orgasm threshold and intensity, assist with premature ejaculation, and work immediately. Reviews posted online by customers clearly indicate the potency and effectiveness of Libigrow products. The company's…

WednesdayMay 04, 2011 8:39 am

Simulated Environment Concepts, Inc. (SMEV) Executives to be Featured in Series of Interviews

Simulated Environment Concepts (SE Concepts), manufacturer and developer of medical, aesthetic, weight loss, wellness, and slimming equipment, announced that Dr. Ella Frenkel, president and CEO of Simulated of the company, and COO Allen Licht will be featured in a weekly series of one-on-one themed interviews in the upcoming weeks. Dr. Frenkel commented, "We are simply continuing with our commitment to full disclosure and open communication with our shareholders. The series of interviews are meant to provide an update on key items discussed during our last shareholder conference call, such as the status of the audit and progress with our co-branding…

TuesdayMay 03, 2011 5:21 pm

New Leaf Brands, Inc. (NLEF) Signs Digital Marketing Agreement

The focus of New Leaf Brands Inc. is to provide consumers with great tasting, healthy beverages. New Leaf Tea is the company's first product line and comes in 14 unique flavors including white, black, blue, and green teas along with four lemonade flavors. The company announced today that it has signed an agreement with Lone Wolf Inc. (LWI), a business development firm specializing in social and digital media marketing. Lone Wolf will help New Leaf Brands take the next step into the digital and social era. New Leaf Brands has already taken some steps along that path. It is well…

TuesdayMay 03, 2011 5:18 pm

BioNeutral Group, Inc. (BONU) Aligning for Growth

BioNeutral Group has had an influx of developments over the last few months. Not only has the Company received Environmental Protection Agency approval for Ygiene® 206, its hospital grade disinfectant, but sales are coming in for its odor neutralizer and multipurpose cleaning unregulated product line, Ogiene®. Equally important, some key milestones have been reached recently. Local U.S. contract manufacturing is under agreement covering both the Ygiene® and Ogiene® technology platforms with the initial 1,000 gallon shipment of Ogiene® products having been manufactured and shipped to Kentucky in advance of initial orders. State approvals are coming in and select municipal vendor…

TuesdayMay 03, 2011 4:46 pm

Metropolitan Health Networks Inc. (MDF) Posts Q1 Earnings and 2011 Expansion Strategy

Metropolitan Health Networks Inc., a leading provider of health care services in Florida, today announced the financial results for their first quarter ended March 31, 2011, reflecting the company’s focus on outward growth for fiscal 2011. The company recognized revenue of $94.7 million for the first quarter of 2011, a 1.8 percent increase compared to $93 million in the first quarter of 2010. Net income for the first quarter was $8.0 million, or $0.20 per basic share and $0.19 diluted, as compared to $7.1 million, or $0.18 per basic share and $0.17 diluted, for the same quarter last year. As…

TuesdayMay 03, 2011 4:45 pm

Adeona Pharmaceuticals, Inc. (AEN) Receives Additional $1.5 Million for MS Drug Clinical Trial

The National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) has given $1,594,553 in grant funding to Adeona Pharmaceuticals, Inc. for the ongoing clinical trial of its TrimestaTM drug (oral estriol) for the treatment of multiple sclerosis. The company recently received a grant of $409,426 from the National Multiple Sclerosis Society (NMSS) also in support of the Trimesta clinical trial. This is in addition to earlier grants for the trial, including $5 million from the NMSS in partnership with the NMSS’s Southern California Chapter, with support from the National Institutes of Health, and $860,440 from the American Recovery…

TuesdayMay 03, 2011 3:42 pm

Kulicke & Soffa Industries Inc. (KLIC) Posts Q2 Results and Strong Q3 Guidance

Kulicke & Soffa Industries Inc., a leading designer and manufacturer of LED assembly equipment, today announced results for its second fiscal quarter ended April 2, 2011. For its second quarter of fiscal 2011, the company reported net revenue of $206.7 million, up 34.4 percent from the comparable quarter of last year. Net income gained 88.5 percent at $39.9 million, or $0.54 per diluted share. Bruno Guilmart, Kulicke & Soffa’s president and CEO, said the company’s second-quarter performance surpassed previous expectations and reflects solid demand for its equipment. “Our results exceeded the high-end of prior guidance, with revenue increasing approximately 39…

TuesdayMay 03, 2011 1:38 pm

Metropolitan Health Networks Inc. (MDF) Posts Q1 Earnings and 2011 Expansion Strategy

TuesdayMay 03, 2011 1:37 pm

Northwest Biotherapeutics, Inc. (NWBO) Launches Cross-country Enrollment for Promising Brain Cancer Treatment

Northwest Biotherapeutics, a biotech company focused on immunotherapy products to treat cancer without toxicities associated with chemotherapies, today announced it has begun enrollment of new patients in the company's ongoing 240-patient randomized, double blind, placebo controlled clinical trial of DCVax® immune therapy for Glioblastoma multiforme (GBM), the most fatal type of brain cancer. So far the company has enrolled 33 patients for the cancer trial and its information arm; patients are already receiving treatment regimen and follow-up. Four recruiting centers are carrying out the company’s enrollment initiatives: the University of Rochester in New York; the University Hospitals of Cleveland in…

Site Search

Company Search

Akorn Inc. (AKRX) to Acquire Advanced Vision Research, Inc.

True 2 Beauty, Inc. (TRTB) Charges Forward with a Superior Product Line and History of Success

Simulated Environment Concepts, Inc. (SMEV) Executives to be Featured in Series of Interviews

New Leaf Brands, Inc. (NLEF) Signs Digital Marketing Agreement

BioNeutral Group, Inc. (BONU) Aligning for Growth

Metropolitan Health Networks Inc. (MDF) Posts Q1 Earnings and 2011 Expansion Strategy

Adeona Pharmaceuticals, Inc. (AEN) Receives Additional $1.5 Million for MS Drug Clinical Trial

Kulicke & Soffa Industries Inc. (KLIC) Posts Q2 Results and Strong Q3 Guidance

Metropolitan Health Networks Inc. (MDF) Posts Q1 Earnings and 2011 Expansion Strategy

Northwest Biotherapeutics, Inc. (NWBO) Launches Cross-country Enrollment for Promising Brain Cancer Treatment

Market Basics

Newsletter Publishers

Public Companies